147 related articles for article (PubMed ID: 2888790)
1. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
[TBL] [Abstract][Full Text] [Related]
2. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Balasubramaniam S; Simons LA; Hickie JB; Chang S
Artery; 1990; 17(2):60-70. PubMed ID: 1968740
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Durrington PN; Brownlee WC; Large DM
Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Shulkin BL; Peele ME; Utiger RD
Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta blockers on blood lipid profile.
Lehtonen A
Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockade with intrinsic sympathetic activity modifies favorably exercise-induced changes in plasma lipoproteins.
Van Nguyen P; Cleroux J; Peterson M; Leenen FH
J Appl Physiol (1985); 1990 Aug; 69(2):485-9. PubMed ID: 1977731
[TBL] [Abstract][Full Text] [Related]
8. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.
Weidmann P; Bianchetti MG; Mordasini R
Curr Med Res Opin; 1983; 8 Suppl 3():123-34. PubMed ID: 6137325
[TBL] [Abstract][Full Text] [Related]
9. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Lehtonen A
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
Vyssoulis GP; Karpanou EA; Pitsavos CE; Skoumas JN; Paleologos AA; Toutouzas PK
Eur Heart J; 1992 Nov; 13(11):1506-13. PubMed ID: 1361175
[TBL] [Abstract][Full Text] [Related]
11. Class III action of beta-blocking agents.
Taggart P; Donaldson R; Abed J; Nashat F
Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Dimmitt SB; Williams PD; Croft KD; Beilin LJ
Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
[TBL] [Abstract][Full Text] [Related]
14. Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
Schoonderwoerd K; Hülsmann WC; Jansen H
Biochim Biophys Acta; 1984 Oct; 795(3):481-6. PubMed ID: 6148107
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
[TBL] [Abstract][Full Text] [Related]
16. Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.
Lehtonen A; Huupponen R; Himanen P
Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):86-90. PubMed ID: 6142007
[TBL] [Abstract][Full Text] [Related]
17. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
[TBL] [Abstract][Full Text] [Related]
18. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
Hall PE; Smith SR; Kendall MJ
Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
Heller FR; Desager JP; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
[TBL] [Abstract][Full Text] [Related]
20. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
